SSR240612 is a potent, orally bioavailable non-peptide antagonist that selectively targets the bradykinin B1 receptor, demonstrating high affinity (Ki = 0.48-0.73 nM) and excellent selectivity over the B2 receptor. It is a valuable research tool for investigating the role of the B1 receptor in pain, inflammation, and neuropathic conditions in both in vitro and in vivo models.